Held in Chicago, IL, the Clinical Lab 2.0 Workshop continued the discussion of progressing the industry from test volume to lab value.
XIFIN was proud to participate as a panelist as well as a sponsor through a silver level educational grant.
Lâle White, Executive Chairman & CEO, XIFIN, Inc.
Monday, November 5, 2018
10:00 AM - 11:30 AM CT
Richard Zarbo, MD, DMD, System Chairman, Pathology and Laboratory Medicine, Henry Ford Health System
Mark Fung, MD, Professor, Director of HLA & Stem Cell Processing Labs, Vice Chair for Population Health, Dept. of Pathology and Laboratory Medicine, University of Vermont Larner College of Medicine
Julie Khani, President, American Clinical Laboratory Association
Myra Wilkerson, MD, Chair, Department of Diagnostic Medicine (Radiology & Laboratory Services), Geisinger
The world of healthcare is changing – the clinical laboratory is changing with it. While the traditional, transactional lab model continues to serve as a foundation, the emerging Clinical Lab 2.0 business model leverages longitudinal laboratory data to produce actionable, clinical insight, driving better outcomes for patients, providers, and financial stakeholders alike. Clinical Lab 2.0 re-engineers the role of lab in the care continuum, aligning with the future of value-based healthcare.